Seeking Alpha

MissionIR's  Instablog

MissionIR
Send Message
We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices. It is our unwavering commitment to connect the investment community with companies that have great potential and a strong dedication to... More
My company:
MissionIR
My blog:
MissionIR Blog
  • NeoStem, Inc. (NBS) Ranked #1 In Tri-State Region 0 comments
    Nov 15, 2012 3:33 PM | about stocks: NBS

    NeoStem today announced that the company has been ranked #1 regionally in the New York Tri-State region and #7 nationally on Deloitte's 2012 Technology Fast 500. The ranking is a list of the 500 fastest growing technology, media, telecommunications, life sciences, and clean technology companies in North America.

    Based in New York, NeoStem is focused on developing cell therapy products, technologies, and procedures. Through its subsidiary Progenitor Cell Therapy, the company is collaborating with Becton-Dickinson in the early clinical exploration of a T-cell therapy for autoimmune conditions. NeoStem's most clinically advanced therapeutic product candidate, AMR-001, is being developed at Amorcyte, LLC, which was acquired by the company in 2011.

    NeoStem's business strategy combines a contract development and manufacturing organization (CDMO) with a medically important cell therapy product development program providing for near- and long-term revenue growth opportunities. The products developed this way are focused on markets for medical products centered around industries such as cardiovascular disease, autoimmune disorders, and regenerative medicine.

    Dr. Robin L. Smith, NeoStem's chairman and CEO, said, "We are proud to be recognized for this achievement as we build NeoStem into a top tier biopharmaceutical company and thrilled to be honored alongside such fast-growing, successful companies such as Celgene, LinkedIn, and Google. On behalf of the entire NeoStem team, I would like to thank Deloitte & Touche, LLP for their recognition of our efforts."

    For more information on NeoStem, visit www.neostem.com

    Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

    Stocks: NBS
Back To MissionIR's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.